Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Baxter
Healthtrust
Medtronic
Merck
McKesson
Boehringer Ingelheim
Express Scripts

Generated: September 19, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Doxycycline Hyclate

« Back to Dashboard

Bulk Pharmaceutical API Sources for Doxycycline Hyclate

Vendor Vendor Homepage Vendor Sku API Url
Calbiochem ➤ Sign Up 324385 ➤ Sign Up
NovoSeek ➤ Sign Up 11256 ➤ Sign Up
NovoSeek ➤ Sign Up 5281011 ➤ Sign Up
NovoSeek ➤ Sign Up 5282244 ➤ Sign Up
NovoSeek ➤ Sign Up 5463942 ➤ Sign Up
ZINC ➤ Sign Up ZINC16052277 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Queensland Health
McKinsey
Deloitte
UBS
US Army
Medtronic
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.